Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CD63 | CTRPv2 | pan-cancer | AAC | -0.28 | 2e-12 |
mRNA | CEP295NL | CTRPv2 | pan-cancer | AAC | -0.25 | 9e-11 |
mRNA | FAM114A1 | CTRPv2 | pan-cancer | AAC | -0.25 | 8e-11 |
mRNA | TIMP2 | CTRPv2 | pan-cancer | AAC | -0.24 | 4e-10 |
mRNA | ATP6V0E1 | CTRPv2 | pan-cancer | AAC | -0.24 | 7e-11 |
mRNA | BCL2L1 | CTRPv2 | pan-cancer | AAC | -0.24 | 7e-12 |
mRNA | ANXA5 | CTRPv2 | pan-cancer | AAC | -0.23 | 7e-08 |
mRNA | MYOF | CTRPv2 | pan-cancer | AAC | -0.23 | 6e-10 |
mRNA | GRAMD3 | CTRPv2 | pan-cancer | AAC | -0.23 | 4e-11 |
mRNA | SLC39A13 | CTRPv2 | pan-cancer | AAC | -0.22 | 1e-08 |